Invasive Pneumococcal Disease in New Zealand, 2010
Invasive Pneumococcal Disease in New Zealand, 2010 Invasive Pneumococcal Disease in New Zealand, 2010
Appendix 6.2010Serotypes among invasive pneumococcal disease cases by age group,SerotypeNumber (% within age group) of IPD cases due to each serotype:
Appendix 7. Serotypes among invasive pneumococcal disease cases and vaccine coverage by agegroup, 2006-07 compared with 2009-10SerotypeProportion (%) of IPD cases within the age group (years) due to the serotype:
- Page 1 and 2: INVASIVE PNEUMOCOCCAL DISEASEIN NEW
- Page 3 and 4: DISCLAIMERThis report or document (
- Page 5 and 6: CONTENTSSUMMARY ...................
- Page 7 and 8: SUMMARYA 4-dose schedule of the 7-v
- Page 9 and 10: 1. INTRODUCTIONPrior to 2009, the n
- Page 11 and 12: Data analyses were performed with S
- Page 13 and 14: 3. RESULTSIn 2010, 535 IPD cases we
- Page 15 and 16: The all-age rate of IPD in 2010 (12
- Page 17: 3.4 Disease incidence by ethnicityT
- Page 20 and 21: 3.7 Risk factors among IPD casesThe
- Page 23 and 24: 3.10 Serotype distributionTable 9.
- Page 25 and 26: Rate per 100 000The rate of disease
- Page 27 and 28: 3.11 Antimicrobial susceptibilityTa
- Page 29 and 30: Percent of penicillin-resistant iso
- Page 31 and 32: type most frequently reported to ha
- Page 33 and 34: REFERENCES1 Green MJ, Cawley PFM. I
- Page 35 and 36: Appendix 1. Laboratory criteria upo
- Page 37 and 38: Appendix 3. Rates of invasive pneum
- Page 39: Appendix 5.2010Risk factors among i
- Page 43 and 44: Appendix 9. Serotype 1 invasive pne
- Page 45 and 46: Appendix 11. Trends in penicillin r
- Page 47 and 48: Appendix 13. Penicillin and cefotax
- Page 49: Appendix 15. Trends in penicillin r
Appendix 6.<strong>2010</strong>Serotypes among <strong>in</strong>vasive pneumococcal disease cases by age group,SerotypeNumber (% with<strong>in</strong> age group) of IPD cases due to each serotype: